NM_001122752.2:c.77T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001122752.2(SERPINI1):​c.77T>C​(p.Ile26Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00114 in 1,614,208 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I26V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 18 hom. )

Consequence

SERPINI1
NM_001122752.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.12

Publications

2 publications found
Variant links:
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
SERPINI1 Gene-Disease associations (from GenCC):
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • familial encephalopathy with neuroserpin inclusion bodies
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004885435).
BP6
Variant 3-167789205-T-C is Benign according to our data. Variant chr3-167789205-T-C is described in ClinVar as Benign. ClinVar VariationId is 235396.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.00108 (1586/1461828) while in subpopulation AMR AF = 0.0183 (817/44724). AF 95% confidence interval is 0.0172. There are 18 homozygotes in GnomAdExome4. There are 666 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 249 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINI1NM_001122752.2 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 9 ENST00000446050.7 NP_001116224.1
SERPINI1NM_005025.5 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 9 NP_005016.1
SERPINI1XM_017006618.3 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 9 XP_016862107.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINI1ENST00000446050.7 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 9 1 NM_001122752.2 ENSP00000397373.2
SERPINI1ENST00000295777.9 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 9 1 ENSP00000295777.5
SERPINI1ENST00000472747.2 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 5 3 ENSP00000420561.2
SERPINI1ENST00000472941.5 linkc.77T>C p.Ile26Thr missense_variant Exon 2 of 3 3 ENSP00000420133.1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
250
AN:
152262
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00844
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0171
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00422
AC:
1060
AN:
251428
AF XY:
0.00316
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.0201
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0176
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00310
GnomAD4 exome
AF:
0.00108
AC:
1586
AN:
1461828
Hom.:
18
Cov.:
31
AF XY:
0.000916
AC XY:
666
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33480
American (AMR)
AF:
0.0183
AC:
817
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26132
East Asian (EAS)
AF:
0.0151
AC:
599
AN:
39688
South Asian (SAS)
AF:
0.000417
AC:
36
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000153
AC:
17
AN:
1111980
Other (OTH)
AF:
0.00180
AC:
109
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00163
AC:
249
AN:
152380
Hom.:
2
Cov.:
33
AF XY:
0.00173
AC XY:
129
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41596
American (AMR)
AF:
0.00843
AC:
129
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0170
AC:
88
AN:
5190
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68040
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000665
Hom.:
1
Bravo
AF:
0.00300
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00318
AC:
386
Asia WGS
AF:
0.0130
AC:
46
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 13, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial encephalopathy with neuroserpin inclusion bodies Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:1
Nov 27, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SERPINI1-related disorder Benign:1
May 23, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
13
DANN
Benign
0.14
DEOGEN2
Benign
0.082
T;T;T;T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.31
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.76
T;.;T;T
MetaRNN
Benign
0.0049
T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.0
.;N;N;.
PhyloP100
4.1
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.37
N;N;N;N
REVEL
Benign
0.24
Sift
Benign
0.16
T;T;T;T
Sift4G
Benign
0.084
T;T;T;T
Vest4
0.0
ClinPred
0.011
T
GERP RS
5.2
Varity_R
0.24
gMVP
0.42
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146948408; hg19: chr3-167506993; API